HomeFundsChrysCapital
Private Equity

ChrysCapital

ChrysCapital backs high-quality Indian businesses at inflection points across consumer, healthcare, financial services, technology, and manufacturing, writing large cheques for Series B and beyond through to buyouts.

Ticket size$30M – $300M
StagesSeries B · Series C+
Sectors2 focus areas

At a glance

Key signals founders use to decide if this investor is worth a conversation.

Where they invest

Stages and sectors this investor typically backs.

Investment thesis

Themes this investor is mapped to across the VC Dekho directory.

All themes →

Portfolio companies

34 companies

Startups this investor has backed — round, amount, date, and source when we can verify them publicly.

Showing 12 of 34

The Sleep Company
Sleep/Comfort Tech
₹480 croreSeries DLead
6 Aug 2025
Awfis
Co-working spaces
$30 millionSeries DLead
6 Aug 2019
awfis.com
Dream11
Gaming/Sports
$225MParticipant
14 Sept 2020
Medial App
Healthcare/Telematics
Participant
AU Small Finance Bank
Financial Services
Axis Bank
Financial Services
Portfolio
CavinKare
Consumer
Acquisition
13 Mar 2017
CORONA
Healthcare & Lifesciences
$90MPrivate Equity
20 May 2021
Cyient
Enterprise Technology
Secondary Exit
20 Jan 2015
Eris Lifesciences
Healthcare & Lifesciences
Rs 1,187 crExit
22 Aug 2024
GeBBS Healthcare Solutions
Healthcare & Lifesciences
9 Sept 2024
GVK Biosciences
Healthcare & Lifesciences
Private Equity
2 Dec 2015

About ChrysCapital

Background and context for founders evaluating this investor.

ChrysCapital is among India's most established private equity platforms, with a consistent focus on backing businesses that have demonstrated model viability and are ready to scale meaningfully. Its investment universe spans consumer, healthcare, financial services, technology, and manufacturing, giving it broad sectoral coverage while maintaining a clear preference for companies at or beyond Series B. Cheque sizes in the range of $30M to $300M signal that ChrysCapital is best suited for founders raising substantial growth rounds or pursuing structured transactions including buyouts. For Indian founders, the practical implication is straightforward: this is not a seed or early-stage conversation. If you are running a capital-efficient business with proven unit economics and are raising a large growth round to accelerate market share, expand geographically, or fund an acquisition, ChrysCapital belongs on your target list. Outreach works best when anchored in hard operational metrics, a clear articulation of the inflection point your business is at, and a specific view on how the capital deployed unlocks the next phase of scale. Warm introductions through advisors, investment bankers, or portfolio founders will significantly improve response rates given the fund's deal volume and selectivity at this stage.

Its investment universe spans consumer, healthcare, financial services, technology, and manufacturing, giving it broad sectoral coverage while maintaining a clear preference for companies at or beyond Series B.

Notes

One of India's oldest and largest PE funds with a long track record in India. Past investments include Mphasis and IndiGrid, reflecting comfort with both technology-driven and infrastructure-oriented businesses. Operates squarely in growth and late-stage territory, not early-stage venture.

Data confidence: Unverified – inferred

Investors at ChrysCapital

Partners and principals mapped to this fund in the directory.

Similar funds

Other funds that overlap on stage, sector, or thesis.

Explore related

Jump into stage, sector, and thesis guides connected to this fund.

VC Dekho

Stop guessing. Start matching.

Search funds by stage, sector, cheque size, and thesis — then unlock deeper matching on VC Dekho.

Browse funds